Zida LLC

Zida LLC manufactures the Zida Control Sock, a FDA-cleared neuromodulation device for at-home treatment of overactive bladder (OAB) and associated urinary symptoms including urge incontinence, urinary frequency, and nocturia. The device uses patented embedded nano-electronics to deliver percutaneous tibial nerve stimulation (PTNS), accessing the tibial nerve at the ankle region to modulate sacral nerve function and regulate bladder control. Clinical data demonstrates over 70% reduction in incontinence episodes. Treatment protocol requires 12 sessions administered once weekly for 30 minutes each. The device is unisex, non-invasive, has no serious side effects, and requires no drug interactions. Zida products are prescribed through US physicians and covered by major insurers including Medicare, Cigna, and Blue Cross. The company serves urology practices, continence clinics, and patients across all age groups seeking non-pharmacological, non-surgical bladder dysfunction management.